Le Lézard
Classified in: Health
Subject: SVY

Australia Endoscope Reprocessing Systems and Software Solutions Market 2018-2022: Market Expected to Reach A$98.7 Million


DUBLIN, July 16, 2018 /PRNewswire/ --

The "Endoscope Reprocessing Systems and Software Solutions Market Assessment, Australia, Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022.

The total number of endoscopy procedures in Australia stood at 3.7 million in 2017. They are expected to grow at a CAGR of 6.5% during 2017-2022 to reach 5.1 million in 2022. While flexible endoscopy procedures accounted for 65.3% of the total procedural volume in 2017, the growth in volume will be equally driven by both rigid and flexible procedures growing at almost equal CAGRs of 6.2% and 6.7%, respectively, during 2017-2022.

Inpatient settings are still the ones taking up higher loads of endoscopic procedures in Australia, accounting for 67.8% of procedures in 2017. Hospitals are expected to dominate the procedural volumes during the forecast period, albeit at a continuously reducing share, accounting for 64.1% of total procedures in 2022, thus losing ground to outpatient and day care settings.

The higher share of hospital-based endoscopy, coupled with growing contribution from outpatient and day care based settings, has led to considerable opportunities for market participants from both end-user types. While hospitals, typically taking care of larger daily volumes, require sophisticated systems and workflow processes in place, day care centers are the ones with smaller volume requirements offering strategic alternatives to market participants in terms of smaller and more effective AER models.

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Drivers and Restraints - Total Endoscope Reprocessing Systems and Software Solutions Market

4. Competitive Environment

5. Australia Endoscopy Devices Market Snapshot

6. Australia Endoscopy and Reprocessing Infrastructure Analysis

7. Forecasts and Trends - Total Endoscope Reprocessing Systems and Software Solutions Market

8. Core Equipment Sub-Segment Analysis

9. Core Equipment Sub-Segment Analysis - Automated Endoscope Reprocessors (AERs)

10. Core Equipment Sub-Segment Analysis - Storage and Drying Cabinets

11. Consumables Sub-segment Analysis

12. Support Products Sub-Segment Analysis

13. Competitive Environment - Endoscope Reprocessing Solutions

14. Software Solutions Sub-segment

15. Competitive Environment - Workflow Solutions

16. Growth Opportunity and Strategic Imperatives for Success

17. The Last Word

18. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/shm3t7/australia?w=5

Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 23:15
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: